PENPenumbra, Inc.
Is the business good?
A genuinely good business: 7 of 9 health tests passed, earnings fully cash-backed (1.9×), and margins widening.
High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.
Operating profit is fully backed by cash. Conversion is improving vs a year ago.
Profits are tracking sales roughly one-for-one, limited operating leverage either way.
A balanced mix of margins, efficiency, and leverage. ROE 12% = margin × turnover × leverage.
Unless marked, from derived.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is PEN?
Penumbra, Inc. earns 17% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.
Return on invested capital · cost of capital 9.0% · 8.0 points above what the capital costs: growth creates value
- Operating margin
- 12%
Operating margin · Medical Devices median 2.1% · 12 months to Q2 2026
- Cash conversion
- 1.88×
Cash conversion · 1.48× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- +0.83%
Share count, year on year · flat: no meaningful dilution
| Year | Operating margin |
|---|---|
| FY2020 | −7.0% |
| FY2021 | −1.0% |
| FY2022 | 0.72% |
| FY2023 | 7.0% |
| FY2024 | 0.78% |
| FY2025 | 13% |
Details›
- Gross margin12 months to Q2 2026
- 68%
- Operating margin12 months to Q2 2026
- 12%
- Net margin12 months to Q2 2026
- 11%
- Free cash flow margin
- 14%
- R&D as % of revenue
- 6.1%
- Revenue, trailing twelve months
- $1.50B
- Free cash flow, trailing twelve months
- $216M
- Net income, trailing twelve months
- $161M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 17%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.